Latest & greatest articles for Priapism

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on Priapism or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on Priapism and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for Priapism

1. Priapism

Priapism Priapism - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Priapism Last reviewed: February 2019 Last updated: March 2018 Summary Pathological condition of persistent (>4 hours) penile erection in the absence of sexual excitation. Classified as ischaemic, non-ischaemic, or recurrent/stuttering. Diagnosis is based on history, clinical findings, and assessment of cavernous blood gases and/or colour duplex (...) ultrasound. Treatment of priapism should progress in a step-wise fashion. Ischaemic priapism warrants emergency management. First-line therapy includes therapeutic aspiration of blood with intracavernous injection of diluted alpha-adrenergic sympathomimetic agents. Surgical shunt procedures are performed in refractory cases. Non-ischaemic priapism is managed by observation. If a patient desires active treatment, selective cavernosal artery embolisation may be considered. Acute episodes of recurrent

2018 BMJ Best Practice

2. Treatments for priapism in boys and men with sickle cell disease. (Full text)

Treatments for priapism in boys and men with sickle cell disease. Sickle cell disease comprises a group of genetic haemoglobin disorders. The predominant symptom associated with sickle cell disease is pain resulting from the occlusion of small blood vessels by abnormally 'sickle-shaped' red blood cells. There are other complications, including chronic organ damage and prolonged painful erection of the penis, known as priapism. Severity of sickle cell disease is variable, and treatment (...) is usually symptomatic. Priapism affects up to half of all men with sickle cell disease, however, there is no consistency in treatment. We therefore need to know the best way of treating this complication in order to offer an effective interventional approach to all affected individuals.To assess the benefits and risks of different treatments for stuttering (repeated short episodes) and fulminant (lasting for six hours or more) priapism in sickle cell disease.We searched the Cochrane Cystic Fibrosis

2017 Cochrane PubMed

4. The Effectiveness of Oral Terbutaline in Treatment of Priapism

The Effectiveness of Oral Terbutaline in Treatment of Priapism BestBets: The Effectiveness of Oral Terbutaline in Treatment of Priapism The Effectiveness of Oral Terbutaline in Treatment of Priapism Report By: Dr. James Enderle - Emergency Medicine Resident Search checked by Dr. Jeff Jones - Research Director, EM Residency Program Institution: Grand Rapids Medical Education and Research Center for Health Professions/Michigan State University Date Submitted: 14th March 2010 Date Completed: 3rd (...) June 2011 Last Modified: 7th June 2011 Status: Green (complete) Three Part Question In [patients presenting to the emergency department with priapism], does the [use of oral terbutaline] result in [detumescence] Clinical Scenario A 46 year old man presents with a painful erection lasting approximately 4 hours. Your attending physician recommends giving oral terbutaline to the patient, but cannot recall the effectiveness of this drug in the treatment of acute priapism. Search Strategy Medline 1948

2011 BestBETS

5. Management of Priapism

Management of Priapism Priapism Guideline - American Urological Association advertisement Toggle navigation About Us About the AUA Membership AUA Governance Industry Relations Education AUAUniversity Education Products & Resources Normal Histology and Important Histo-anatomic Structures Urinary Bladder Prostate Kidney Renovascular Diseases Andrenal Gland Testis Paratesticular Tumors Penis Retroperitoneum Cytology Online Learning For Medical Students Exams/LLL/Certifications Exam Prep Research (...) and Reporting Patient Education Management of Priapism (2010) Published 2003; Reviewed and Validity Confirmed 2010 Priapism, a relatively uncommon disorder, is a medical emergency. Although not all forms of priapism require immediate intervention, ischemic priapism is associated with progressive fibrosis of the cavernosal tissues and erectile dysfunction. This clinical guideline discusses evaluation, ischemic priapism, non-ischemic priapism, and stuttering priapism. [pdf] Panel Members Drogo K. Montague, MD

2010 American Urological Association

6. Treatments for priapism in boys and men with sickle cell disease. (PubMed)

Treatments for priapism in boys and men with sickle cell disease. Sickle cell disease comprises a group of genetic haemoglobin disorders. The predominant symptom associated with sickle cell disease is pain resulting from the occlusion of small blood vessels by abnormally 'sickle-shaped' red blood cells. There are other complications, including chronic organ damage and prolonged painful erection of the penis, known as priapism. Severity of sickle cell disease is variable, and treatment (...) is usually symptomatic. Priapism affects up to half of all men with sickle cell disease, however there is no consistency in treatment. We therefore need to know the best way of treating this complication in order to offer an effective interventional approach to all affected individuals.To assess the benefits and risks of different treatments for stuttering (repeated short episodes) and fulminant (lasting for six hours or more) priapism in sickle cell disease.We searched the Cochrane Cystic Fibrosis

2004 Cochrane

7. The management of priapism

The management of priapism Guidelines and Measures | Agency for Healthcare Research & Quality HHS.gov Search ahrq.gov Search ahrq.gov Menu Topics A - Z Healthcare Delivery Latest available findings on quality of and access to health care Searchable database of AHRQ Grants, Working Papers & HHS Recovery Act Projects AHRQ Projects funded by the Patient-Centered Outcomes Research Trust Fund You are here Guidelines and Measures Funding for the National Guideline Clearinghouse (NGC) has ended. Learn

2003 American Urological Association Education and Research, Inc.

8. Stilboestrol and stuttering priapism in homozygous sickle-cell disease. (PubMed)

Stilboestrol and stuttering priapism in homozygous sickle-cell disease. A double-blind, placebo-controlled crossover study was conducted in 11 patients with stuttering attacks of priapism and homozygous sickle-cell (SS) disease. Stilboestrol 5 mg daily was better than the placebo in preventing attacks.

1985 Lancet